A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, today announced the appointment of James Kehler, VMD, PhD, as Head of Avian Sciences. Dr. Kehler joins Neion ...
Trained Therapeutix Discovery, a biotechnology company founded by the Jean Boulle Group and the Heritage Group, today announced that its Chief Scientific Officer and scientific founder, Willem Mulder, ...
The Biomedical Sensor Market is experiencing significant momentum driven by the increasing prevalence of chronic diseases, rising demand for continuous health monitoring, and rapid integration of ...
Morning Overview on MSN
AI-built proteins designed from scratch detect specific compounds
A team of researchers at the Korea Advanced Institute of Science and Technology (KAIST) has used artificial intelligence to ...
Deloitte has noted that digital transformation in life sciences manufacturing can boost operational efficiency by streamlining processes, increasing productivity and reducing errors. AI systems can ...
Harvard's Wyss Institute and Emulate Bio say results from the AVATAR project could provide insights on how travel into deep ...
According to Mordor Intelligence, the synthetic biology market size was valued at USD 19.75 billion in 2025 and is projected to grow to USD 23.53 billion in 2026, reaching an estimated USD 56.48 ...
InvestorsHub on MSN
The intersection of biotechnology, advanced materials, and molecular biology
Hello, I’m Ricki Lee, and this is The Capital Compass. Today we’re taking a look at Kraig Biocraft Laboratories (USOTC:KBLB), ...
Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from the Government of Canada.
Spread the loveIn a bold move that underscores Texas’s growing significance in the biotech sector, Ben Lamm, the visionary behind the $10 billion-valued Colossal Biosciences, has launched a new ...
MXene materials have rapidly emerged in the field of two-dimensional materials due to their unique combination of transition metal carbides, nitrides, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results